Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
With
Biogen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
No prior use of Rituxan (except if received within 8 weeks of screening)
Signed Informed Consent Form
Age ≥ 18 years
Diagnosis of RA
Inadequate response to one or more anti-TNF therapies
You may not be if
Have known hypersensitivity to any component of a humanized or murine monoclonal antibody
Clareo Health | A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)
